EBF1,MYO6CALRB

Alice Turdo1, Miriam Gaggianesi2, Caterina D'Accardo1

  • 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.

Frontiers in immunology
|November 30, 2023
PubMed
概括

识别基因表达特征可以预测扩散性大B细胞淋巴瘤 (DLBCL) 治疗反应. 像EBF1,MYO6和CALR这样的特定基因表明,在接受R-CHOP治疗的DLBCL患者的生存率更差.